All Activity

“We thought they were going to come in and do the right thing, and they’re not. They’re doubling down, and they’re lying about it, which is even worse.” By Sophie Nieto-Muñoz, New Jersey Monitor A state appellate court earlier this month sided with two Jersey City cops who say they shouldn’t have been fired for their off-duty cannabis use, but it’s unknown what the next steps are in this yearslong fight over New Jersey’s marijuana legalization law. A spokesman for James Solomon, a Democrat who became the city’s new mayor in January, said the city is reviewing the policies of Solomon’s predecessor, Steve Fulop, who argued that federal law prevents armed police officers from using cannabis at any time. But the officers’ lawyer, Michael Rubas, said the city has refused to return them to their old jobs despite several rulings that they should be reinstated. “I’m very disturbed by the way the Solomon administration has been handling things. We thought they were going to come in and do the right thing, and they’re not,” Rubas said. “They’re doubling down, and they’re lying about it, which is even worse.” Solomon spokesman Nathaniel Styer declined to respond to Rubas’s charges, but indicated the mayor’s view on police officers using cannabis while off duty differs from how the city operated under Fulop. “We are reviewing those policies as they are not in line with our views and values,” said the spokesman, Nathaniel Styer. The dispute dates to 2022, a few months after New Jersey’s legal recreational cannabis market opened. The state Attorney General’s Office told police departments then that the state’s marijuana legalization law does not allow them to discipline officers for using cannabis off duty, but Fulop argued that federal law prohibits anyone who uses a controlled substance from possessing a firearm. In September 2022, two Jersey City cops, Norhan Mansour and Omar Polanco, tested positive for cannabis they claimed they bought on the legal market. The city suspended and then fired them, but administrative law judges and later the state Civil Service Commission sided with the officers and ordered the city to reinstate them. The officers were placed on modified duty in 2024 but they were not returned to their previous positions. The city appealed both rulings, and on May 1, a state appellate panel ruled in the officers’ favor. A separate decision involving a third police officer upheld that officer’s termination because he bought cannabis from an unlicensed individual. Rubas said Mansour and Polanco are each owed hundreds of thousands of dollars in back pay, and have not had their firearm ID cards or their weapons returned to them. Spokespeople for Jersey City did not respond to multiple requests asking about the officers’ guns. A spokesperson for the Attorney General’s Office declined to comment. The officers still have to get their police licenses reissued by the state Police Training Commission, Rubas said, adding that if the city cooperated the officers could be reinstated to their typical posts within a week. Rubas said he’s reached out to the Solomon administration multiple times, including shortly after Solomon took office, to attempt to resolve the issue. He said he was hoping the city’s stance would change once Fulop left office. “Nothing’s changed at all. It’s been worse,” he said. This story was first published by New Jersey Monitor. The post New Jersey Police Fired For Off-Duty Marijuana Use Still Haven’t Been Reinstated Despite Court Ruling In Their Favor appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

“This is what we call the ‘Texas whiplash.’ These poor guys don’t know what is going to happen one day to the next. All they want is certainty and to sell their products.” By Paul Cobler, The Texas Tribune Hemp flower buds and rolled joints were piled into boxes and tucked out of public view by the staff of Dream Planet Smoke and Vape last Thursday after the state filed an appeal that triggered an hourslong ban. By Friday, the items were back on the store shelves, and are flying off them once again as customers rush to stock up while they still can, said Leroy Sims, a cashier at the East Austin smoke shop. “My boss is really big on keeping us all informed because he’s aware of the fact that Texas can’t really make its mind up,” Sims said. “We just put stuff in a box until they can make a decision because we can’t send it anywhere else to sell.” Some of the most profitable products at smoke shops around Texas have been forced off store shelves, then allowed back on, then forced off again, then allowed to return—all within a 45-day span—amid a dizzying slew of court actions centered on the state’s ban on smokable hemp products. This ping-ponging regulatory landscape in recent months has injected economic uncertainty into and bled revenue for an industry that employs more than 30,000 people around the state. “This is what we call the ‘Texas whiplash,’” said David Sergi, an attorney for the hemp industry. “These poor guys don’t know what is going to happen one day to the next. All they want is certainty and to sell their products.” While the percentage varied at each shop that spoke to The Texas Tribune, managers and cashiers said smokable hemp products make up a sizable portion of their total profits. The uncertainty surrounding a potential ban on their sales is already leading to employees losing their jobs, hours being cut back and plans being made to close store locations. The ultimate fear is that customers will soon start losing access to some of their favorite products even before the courts permanently rule on the ban. Austin Vape & Smoke is eyeing closing its less popular location near the University of Texas at Austin campus, leaving a handful of employees out of work, and cutting back on hours at their South Austin location, said Zaquiri Hensen, a manager at the South Austin store. About 43 percent of the company’s sales are smokable hemp products. “It…sucks,” Hensen said, using an expletive to emphasize his frustration with the recent uncertainty. “We’re lucky that we don’t really have any turnover, so a lot of our guys have been working here for a long, long time. I’m very close with them.” Texas smoke shops have had the opportunity to plan for a ban because it has already happened twice in recent months as the Texas Department of State Health Services’ efforts to further regulate the consumable hemp industry is challenged in state courts. A statewide ban on the sale of smokable hemp went into effect on March 31 under rules imposed by the public health agency. Smoke shops briefly pulled the products from their shelves until a Travis County district judge on April 10 temporarily lifted the ban until May 1 as a lawsuit by the hemp industry challenged the ban played out in court. Earlier this month, a judge ruled to extend the ban until the next hearing in the district courts, scheduled for July 27, but because the 15th Court of Appeals agreed to considering the state’s appeal, the ban was back in effect last Thursday. That ban only lasted for some hours—briefly forcing the products off store shelves again—until the appeals court last Thursday allowed the sale of the smokable flower. The next ruling on whether or not the injunction will stand is expected in the coming weeks. If the appeals court blocks the injunction, the ban will remain in effect at least until the district court’s July 27 hearing. The regulatory effort to ban smokable hemp began last fall after an effort to completely ban consumable hemp products failed in the Legislature. Lt. Gov. Dan Patrick (R) and other conservative legislators leading the effort argued the products are dangerous to Texans and must be banned. Rather than keep the Legislature in Austin for a special session on the topic, Gov. Greg Abbott (R) ordered DSHS and the Texas Alcoholic Beverage Commission to create stricter regulations on the products, which culminated with the state health agency’s ban of smokable hemp. Abbott referred a request to comment to DSHS, which referred a request for comment to Abbott’s fall executive order. Patrick did not respond to a request for comment. Businesses are working to comply with changing state laws and regulations, all while enforcement raids of smoke shops have picked up in recent years. But following the recent flurry of court actions has proved challenging. “I wasn’t even aware it was illegal because the last I had heard we were good to sell it until July 27,” Anthony Vazquez, owner of Dooby’s Smoking Depot in south-central Austin, said of last week’s hours-long ban. “I didn’t get any messages saying that it was gone. It wasn’t brought to my attention until Friday when I went to my distribution company and they were pulling the stuff back out on roller carts again.” Other smoke shops have been following the court proceedings in group chats with thousands of members created by the state’s largest trade association for the industry and one of the plaintiffs in the case, the Texas Hemp Business Council. Others said they are closely following updates in the news and pass the updates on to their customers. More than half of the sales at Dream Planet are smokable hemp, Sims said, and the company’s three locations may work to transition away from the products regardless of the court rulings because of the ongoing uncertainty. Sam Mafza, a cashier at La Casa Smoke Shop in East Austin, said 50 percent of the sales at his store are smokable hemp, and they have already cut back on hours. Mafza said he has a friend at a different smoke shop who recently lost his job due to the uncertainty. “Everybody is watching this,” Mafza said. “You can’t just abandon a product everybody uses.” The Texas Hemp Business Council, Hemp Industry & Farmers of America, and several Texas-based dispensaries and manufacturers have been fighting the state’s new testing requirements that create a 0.3 percent total THC threshold that would effectively bar the sale of natural smokable hemp products. The state also created a 3,000 percent increase in licensing fees for hemp retailers. During a three-day hearing before the district court on the injunction, attorneys for the state argued that Texas law requires the health agency to prioritize Texans’s well-being in rulemaking, allowing them to implement new hemp regulations. Lawyers for the hemp industry argued that the state’s public health agency overstepped its constitutional authority by rewriting the legal definitions of hemp to make it different from what lawmakers passed in 2019, and the ban would put stores out of business. Cynthia Cabrera, president of the Texas Hemp Business Council, said the effects of a ban go far beyond smoke shops, harming farmers that grow hemp, suppliers that manufacture the products, packaging companies, transportation and consumers. Beau Whitney, the founder and chief economist at Whitney Economics, a cannabis economic research firm, told the district court that the new rules and regulations will have a $7.2 billion negative impact on the Texas economy due to job losses and reduced tax revenue from hemp retail closures. “The ripple effects are far, wide and deep,” Cabrera said. In the meantime, the business council is simply trying to keep its members informed of the fast-moving legal landscape, Cabrera said. While smoke shops await clarity from the courts, many stores are trying to diversify their merchandise, such as hemp edibles and drinks, that will not be banned under the new rules, she said. Many are also trying to move their products through their stores as quickly as possible, offering promotions like buy two get one free for joints and other discounts on smokable flower buds. If a full ban goes into effect, “I just have to take a loss on everything,” Vazquez said. “I’d rather have cash than be stuck with a bunch of weed.” This article first appeared on The Texas Tribune. The post Texas’s On-Again, Off-Again Hemp Product Ban Causes Confusion For Businesses And Consumers appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Regards just for featuring brand-new upgrades in connection with priority, Document wait for look at a great deal more. linen tailor bangkok

“This is a healthcare program. This is for the health of our patients in Alabama, and it says we are not a recreational program.” By Anna Barrett, Alabama Reflector Patients in Alabama with qualifying medical conditions are “days away” from being able to purchase medical cannabis with a physician’s recommendation, according to Vince Schilleci, owner of a dispensary. Callie’s Apothecary in Montgomery will be the first medical cannabis dispensary to open in Alabama. When the program is fully up and running, there will be 12 dispensaries across the state between four companies. “Our goal is to get any questions answered, but get our patients in and out of here quickly, efficiently, do it in a professional manner, but most importantly, be compassionate,” said Vince Schilleci, owner of dispensary Callie’s Apothecary, Thursday morning during a tour. “These patients are dealing with issues, pain, and dealing with them for a while.” Schilleci would not give a specific date for the Montgomery location’s opening because it depends on the testing of the products and delivery. He said the order for the first round of product has been placed from the processor, but when it will be delivered cannot be certain. “We have to remember this product is not like potato chips or something that’s easy to ship, and we have testing that it has to go through. We have to get it into the state’s seed-to-sale tracking system,” Schilleci said. “There’s a lot of moving parts, but we’re close.” Three of the companies, CCS of Alabama, LLC, GP6 Wellness, LLC, and RJK Holdings, LLC, have licenses and are expected to open their storefronts this summer, according to Alabama Medical Cannabis Commission Director John McMillan. A fourth license is pending litigation, but is likely to go to Yellowhammer Medical Dispensaries, LLC. “We’re very anxious to move forward so we can become what the Legislature envisioned, and the public and patients need,” McMillan said in a phone interview Thursday afternoon. The Alabama medical cannabis law, enacted in 2021, allows registered physicians to recommend cannabis for about 15 medical conditions, including cancer, depression, Parkinson’s Disease, PTSD, sickle-cell anemia, chronic pain and terminal diseases. The approved product forms are restricted to tablets, tinctures, patches, oils and gummies (only peach flavor), with raw plant material and smokable forms remaining prohibited. People who suffer from the qualifying conditions must get approval from their physician and enter the patient registry in order to buy products at a dispensary. Litigation has also held up access to medical cannabis. Some firms sued the commission for not being awarded a license, citing a discriminatory process. Another case involved five parents that sued the commission over delays in access to cannabis, which was dismissed in August. McMillan said that there were 181 patients registered with the commission as of Monday. As of Thursday, there are 43 physicians certified to recommend medical cannabis to patients in Alabama, according to the Alabama Board of Medical Examiners. Schilleci said that Callie’s is just waiting on products to be delivered before it can open. Once it does, patients will present their “cannabis card” that their recommending physician will give them in order to enter the storefront. They will then sign in and enter a pharmacy-like room where they can receive consultation from dispensary staff and select a cannabis product. “This is a healthcare program. This is for the health of our patients in Alabama, and it says we are not a recreational program,” Schilleci said. “You just can’t come in here and buy something. You’ve got to go through the process of getting the card and going and making sure you have a qualifying condition.” Schilleci said he is unsure of the total price of each product, but their estimates are lower than their original estimates when they applied. In 2023, Schilleci said CCS estimated that patients would pay $65 for a supply of cuboids, or gummies. “As time moves on and we have more as the processors get comfortable with the program, I think you’ll start seeing the more advanced, gel caps, or maybe transdermal patches, perhaps inhalers and nebulizers and things like that,” Schilleci said. Alora Frank, the area manager at Callie’s, worked in the medical cannabis industry in Florida before moving to Alabama, her home state, to work at the Montgomery dispensary. “On your first visit, there’s a lot of nerves, a lot of fear, there’s a lot of stigma around using this as an alternative medical product. But after their first visit, that second, that third visit, when you start to see people come in and they tell you, ‘Wow, I was able to stop this medication, stop that medication.’ Or you have a patient that had to come in with a wheelchair, and then can come in on their own power. It’s very, very fulfilling,” Frank said. “We are dosing cannabis, but we get doses of humanity back.” Dispensary Locations: CCS of Alabama, LLC Montgomery, Bessemer and Talladega GP6 Wellness, LLC Birmingham, Athens and Attalla RJK Holdings, LLC Oxford, Daphne and Mobile Yellowhammer Medical Dispensary, LLC *pending license approval Birmingham, Owens Cross Roads and Demopolis This story was first published by Alabama Reflector. The post The Launch Of Alabama Medical Marijuana Sales Is Just ‘Days Away,’ With First Dispensary Preparing To Open Its Doors appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

I simply believed it might be a concept to publish in case other people had been having issues studying however I'm just a little uncertain basically 'm permitted to place titles as well as handles upon right here. Chiffon print fabric bangkok

Yes, I am entirely agreed with this article, and I just want say that this article is very helpful and enlightening. I also have some precious piece of concerned info !!!!!!Thanks. 성인 피시방

I got too much interesting stuff on your blog. I guess I am not the only one having all the enjoyment here! Keep up the good work. 성인 피시방

i really like this article please keep it up. Tailor who has fabrics for women

Great article Lot's of information to Read...Great Man Keep Posting and update to People..Thanks 피씨365

Awesome article, it was exceptionally helpful! I simply began in this and I'm becoming more acquainted with it better! Cheers, keep doing awesome! Bangkok proposal photographer

This is my first time i visit here. I found so many interesting stuff in your blog especially its discussion. From the tons of comments on your articles, I guess I am not the only one having all the enjoyment here keep up the good work Tailor with premium fabrics bangkok

Just admiring your work and wondering how you managed this blog so well. It’s so remarkable that I can't afford to not go through this valuable information whenever I surf the internet! Best creative agencies bangkok

Excellent article. Very interesting to read. I really love to read such a nice article. Thanks! keep rocking. Top 10 cafes bangkok

Such a great breakdown of the pillars! If you want to see this practically, find a BaZi Calculator and pull up your BaZi Chart. It is amazing to see your destiny elements laid out clearly without any guesswork. My BaZi reading gave me so much clarity on my life purpose and the direction I need to take!

A beautiful Aerocity Escort from our agency is all you need to turn a dull evening into a festival. Our handpicked VIP models and air hostesses provide private companionship that arouses passion and offers boundless pleasure. They excel at engaging conversation and intimate moments, making you feel like the center of their universe. Contact us now to book a session that promises unbelievable ecstasy and total relaxation.

A Republican congressman who plans to imminently file legislation to federally regulate hemp-derived products in place of a ban that’s currently scheduled to go into effect later this year says the plan faces opposition from a coalition of strange bedfellows that includes sectors of the alcohol industry, marijuana businesses and cannabis legalization opponents. Rep. Andy Barr (R-KY) said during a Zoom meeting with members of the group Hemp Industry & Farmers of America (HIFA) on Thursday that his bill will create “a regulatory and tax framework” that “would provide a lifeline and a…durable legal pathway for this marketplace,” according to a transcript obtained by Marijuana Moment. Hemp derivatives with less than 0.3 percent delta-9 THC on a dry-weight basis were federally legalized under the 2018 Farm Bill that President Donald Trump signed during his first term in office. But late last year, Trump signed new legislation containing provisions that will redefine hemp to make it so only products with 0.4 milligrams of total THC per container will remain legal after November 12. Barr said the planned recriminalization of hemp THC products would “jeopardize the existing crop that is in storage right now” after having been grown by farmers and would upend “future opportunities to cultivate this this crop.” “So that’s why we need this legislation to establish a regulatory framework and create a level playing field with other similar products, especially in the drink category,” he said, according to the meeting transcript. “We want to create kind of a level playing field with other adult beverages so that farmers will have certainty that they can sell into a mature marketplace with protections that achieves both what we want it to achieve—for safety, for targeting age-appropriate consumers—but also helping our farmers all the way through.” But the effort is facing opposition not just from prohibitionist forces but also from segments of the alcohol industry as well as marijuana businesses that sell cannabis products under limited state-based licensing systems, according to the congressman. Producers of distilled spirits have an “understandable concern about competition” from hemp-derived THC drinks, Barr said. Companies in the wholesale tier of the alcohol industry could be an ally, he added, “because they want to distribute” cannabis beverages. “I think the wholesalers want a three-tier system, so we have worked to try to achieve that with, again, a level playing field where you would have exceptions for direct-to-consumer, where it would make sense that it’s on a state-by-state level,” he said. “We recognize that distilled spirits and other adult beverage groups don’t want competition. That’s natural. But what we want is regulation and tax… We want a level playing field. Competition and choice is something I believe in. And giving consumers choices. Competition’s a good thing… You’re looking at one of the most adamant defenders of the bourbon industry. I’m co-chairman of the Congressional Bourbon Caucus. I don’t think you have to choose. I think you can be an advocate of both hemp products and Kentucky bourbon. So the issue is a level playing field.” “Then you have the prohibitionists,” the congressman said. “And they’re just there, and they may not be persuadable, but they exist.” “And then finally, there’s another category out there, and that’s the marijuana industry that views this as competition as well,” Barr said, per the transcript of the meeting. “They will want to push the industry into specialized dispensaries. My view is that that is not a level playing field. Maybe that’s appropriate for the marijuana industry, but I don’t believe that’s appropriate for this hemp-derived product industry.” Join HIFA & Rep. Andy Barr on TODAY at 3:45 PM ET to discuss the bipartisan LAWFUL HEMP PROTECTION ACT – protecting a $50B+ industry & 475,000+ jobs. Register: https://t.co/KMo9TbD9Y9 pic.twitter.com/S4w7bdTEAR — Hemp Industry & Farmers of America (@hifa_health) May 14, 2026 Barr’s forthcoming bill, which is titled the “Lawful Hemp Protection Act” in draft versions that Marijuana Moment has seen, would institute age limits labeling requirements for hemp products, subject to Food and Drug Administration (FDA) oversight. There would also be taxes on hemp products administered by the Treasury Department’s Alcohol and Tobacco Tax and Trade Bureau (TTB). Meanwhile, White House officials recently provided Barr’s office with feedback on pending legislation to create a regulatory framework for hemp. Last month, Vince Haley, director of the White House Domestic Policy Council and James Braid, assistant to the president for legislative affairs, sent hemp policy suggestions to the congressman’s office. “We appreciate your work to advance the policy of” an executive order Trump signed in December that included provisions seeking to protect Americans’ access to CBD products, the staffers wrote in a letter to the congressman. “We are transmitting for your consideration draft legislative text and comments to address the statutory definition of final hemp-derived cannabinoid products in order to allow Americans to benefit from access to appropriate full-spectrum CBD products while preserving the Congress’s intent to restrict the sale of products that pose serious health risks,” the White House officials said, according to a social media post containing a screenshot of the letter. “We are available for discussion and further technical assistance.” The attachment with the administration’s proposed legislative text has not been publicly released, and the White House and Barr’s office did not respond to Marijuana Moment’s requests for further details. At Thursday’s meeting with hemp business representatives, the congressman said there’s “tremendous opportunity in agriculture, in farming, and in this industry generally,” according to the transcript. “I come from Central Kentucky. All four of my grandparents were born and raised in central Kentucky. I was raised in central Kentucky. And once upon a time, that was the burley tobacco capital of the world. Since the decline in tobacco production, our farmers have been looking for alternatives. And industrial hemp and hemp-derived products has created a huge marketplace and tremendous opportunity. And in the consumer marketplace, this has created some choices for consumers. I look forward to working with the industry to provide some stability and certainty so that this industry can be viewed properly as a mature industry, so that there’ll be some durability to the law and decrease the uncertainty that currently exists, so that this market can thrive.” Barr also said cannabis products can provide a safer alternative to prescription medications, especially for military veterans. “To the extent we can promote opioid alternatives or opioid avoidance and help veterans with anxiety or sleep deprivation or insomnia or post-traumatic stress, that’s exactly what we want to do, is to create those options for our veterans to take care of them,” he said. “We think this is a great option for our veteran community.” HIFA officials on the call said they expect Barr’s bill to be filed within the next week, though the expected timeline for the legislation has already shifted back a few times over the past several weeks as Barr has engaged stakeholders, tweaked draft provisions and sought initial cosponsors to join him in introducing the proposal. The House of Representatives recently passed a Farm Bill with provisions aimed at aiding industrial hemp producers—but without any language to delay or alter the federal recriminalization of hemp THC products that’s scheduled to take effect in November. Trump last month pushed congressional lawmakers to take action to amend the currently scheduled hemp ban, which he suggested threatens to federally recriminalize full-spectrum CBD products. “I am calling on Congress to update the Law to ensure that Americans can continue to access the full-spectrum CBD products they have come to rely on, and that help them, while preserving Congress’s intent to restrict the sale of products that pose Health risks,” the president said in a Truth Social post on Thursday, the same day his administration announced it is moving forward to reschedule marijuana. “We must get this done RIGHT and FAST, especially for those who saw that CBD helps them,” he said. “Plus, I am told it will also help our GREAT FARMERS, who we love, and will always be there for.” Major retailer Target, meanwhile, recently moved to expand its sales of hemp THC drinks into more states. The Wine & Spirits Wholesalers of America (WSWA), for its part, said the House’s failure to include provisions to delay or alter the ban on hemp THC products was a “missed opportunity.” “A ban will not remove these products from the market—it will push consumers toward unregulated, online channels with no age verification, no product standards and no accountability,” Dawson Hobbs, executive vice president of government affairs for WSWA said. The post GOP Congressman Says His Hemp Regulation Bill Faces Opposition From Alcohol, Marijuana And Prohibitionist Groups appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Studies “consistently show” that the non-intoxicating marijuana component CBD is a potential “anticancer agent across different cancer types”—and that effect applies to dogs as well as humans, according to a new systemic review of the scientific literature. Numerous studies have investigated how cannabis and its constituents may impact the symptoms and progression of cancer. The new paper published in the journal Frontiers in Veterinary Science examined that preclinical research, which generally indicates that CBD may “inhibit cell proliferation and migration, while inducing apoptosis in various human tumor cells.” How cannabidiol affects canines has been less rigorously studied compared to humans. That’s despite the fact that the cannabinoid “has been shown to be safe and well-tolerated in dogs, supporting its potential clinical use,” the authors, who are affiliated with the University of Chile, said. They wrote that since 2015, “some studies have been conducted evaluating CBD in different types of canine cancer,” but “no comprehensive review of these findings has been performed.” “For this reason, we conducted a systematic review to compile the existing evidence on the anticancer effects of CBD in dogs,” they said, adding that their analysis determined that preclinical studies, largely based on cellular models, often focus on “lymphoma, mammary cancer, glioma, prostate cancer, osteosarcoma, and urothelial carcinoma.” “These studies consistently show that CBD exerts antiproliferative and proapoptotic effects, in some cases by modulating intracellular signaling pathways,” the review said. “Additionally, some studies have evaluated the combination of CBD with other drugs, reporting both synergistic and antagonistic effects.” “Overall, these findings highlight the potential of CBD as an anticancer agent across different cancer types. However, further studies are required to better elucidate the mechanisms underlying the effects of CBD and to standardize concentrations and formulations, enabling reliable, comparable results and the development of clinical studies evaluating the role of CBD in canine oncology.” The study review builds upon a sizable body of research on the therapeutic potential of cannabis in cancer treatment. For example, another recent scientific review found that CBD “holds substantial promise as an anti-tumor agent” in addition to its other anti-inflammatory properties. Scientists explored CBD’s effect on many types of cancer—including some of the most aggressive ones, such as glioblastoma, which affects the brain. They also noted it can help suppressing the growth and metastasis of other cancers, including breast, lung, colorectal, ovarian and prostate, among others. In 2025, a paper published in the journal Pharmacology & Therapeutics, assessed a range of clinical and preclinical findings that the efficacy of chemotherapy drugs can be enhanced by medical marijuana. In a sign of greater acceptance of medical applications of cannabis, President Donald Trump’s choice to serve as the next White House drug czar has called medical marijuana a “fantastic” treatment option for seriously ill patients and said she doesn’t object to legalization, even if she might not personally agree with the policy. Also last year, a study found that “patients with cancer using cannabis report significant improvements in cancer-related symptoms.” With respect to canine research, a case study in the journal Veterinary Medicine and Science published last year suggests that very small doses of the psychedelic LSD appeared to ease a dog’s severe separation anxiety, reducing destructive behavior and shortening the duration of vocalizations. the National Animal Supplement Council (NASC) promoted a study in 2024 that it said shows CBD is “safe for long-term use” in dogs—a significant finding given emerging research that cannabis can effectively treat conditions such as anxiety and certain skin diseases among canines. Another 2024 case study found that cannabis appears to be a “viable alternative” treatment option for dogs suffering from a common skin disease, especially if they experience adverse side effects from conventional steroid therapies. The post CBD Holds Potential As An ‘Anticancer Agent’ For Dogs, New Scientific Review Concludes appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Sen. John Fetterman (D-PA) is giving some across-the-aisle credit to President Donald Trump for his administration’s moves to federally reschedule marijuana and accelerate therapeutic access to psychedelics. “I think we could all agree [on] everything that President Trump has done about liberalizing marijuana and psychedelics and now too,” Fetterman said in an interview published by Reason on Wednesday. “I really am very, very libertarian in a lot of ways and for those circumstances,” the senator said. “If you check my record, I’ve been for legal weed for forever in that. Politically, that was toxic or certainly not popular. And also psychedelics too.” “As a libertarian I don’t judge or knock anyone for whatever that they knock their edge off to just make it through in this world,” he said, pointing to his opposition to a crackdown on the nicotine product Zyn, an issue on which he has clashed with other Democrats. “I absolutely support Zyn and those things as long as it’s legal, safe too,” Fetterman said. “I think that’s important. That’s a choice that every American of legal age deserves to have, and to participate in a way that doesn’t turn them into a criminal or judge [them] for those things—make it as safe as possible.” The senator said the right to choose to relax with whatever substances one wants, as long as it doesn’t hurt anybody else, is “sacred.” “Whatever that is. A glass of wine or scotch or sip a little weed, whatever, sitting in front of the fire pit in your backyard.” he said. “Whatever that is. I think your path for wellness, psychedelics, whatever. I think it all should be legal without judgment and without punishment or a criminal record.” “I’ve been very consistent about that and sharing those things,” Fetterman, who has championed cannabis reform since he served as Pennsylvania’s lieutenant governor, said. “So I do hope it continues to liberalize for that, overall.” The Department of Justice last month formally moved state-regulated medical marijuana products from Schedule I of the Controlled Substances Act to Schedule III. A hearing scheduled to begin next month will consider the issue of broader cannabis rescheduling. Also last month, Trump signed executive order aimed at expanding and expediting research on the potential therapeutic benefits of psychedelics. Shortly thereafter, the Food and Drug Administration (FDA) and Department of Health and Human Services (HHS) announced steps that they say will help with “accelerating” therapeutic access to psychedelics for patients dealing with serious mental health conditions. Fetterman, for his part, has criticized Pennsylvania GOP lawmakers for holding up marijuana legalization as neighboring states like Ohio move forward with the policy change. Last year, the senator’s campaign launched a petition supporting federal marijuana legalization. He previously criticized President Joe Biden for excluding military-level cannabis policy violations from his mass marijuana pardons. The post Fetterman Praises Trump’s Marijuana And Psychedelics Reform Moves appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Anti-rescheduling provision advances in Congress; Lawmaker: “a lot” of colleagues smoke marijuana; LA medical cannabis in hospitals; Psychedelics poll Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Get our daily newsletter. Email address: Leave this field empty if you're human: Your support makes Marijuana Moment possible… Your good deed for the day: donate to an independent publisher like Marijuana Moment and ensure that as many voters as possible have access to the most in-depth cannabis reporting out there. Support our work at https://www.patreon.com/marijuanamoment / TOP THINGS TO KNOW The House of Representatives passed amendments to allow military veterans to get medical cannabis recommendations from their Department of Veterans Affairs doctors and to raise awareness about the benefits of psychedelic therapies. The House Appropriations Committee approved a spending bill containing a provision to block marijuana rescheduling action by the Department of Justice—but also including a longstanding rider protecting state medical cannabis laws from federal interference. Rep. Ilhan Omar (D-MN) said “there are a lot of people who smoke cannabis in Congress”—adding that “advocacy for legalizing doesn’t necessarily mean that you are a user.” “So everybody can be an advocate for legalizing it, because we understand that it is not okay for us to spend the billions of dollars we do now on incarcerating people for smoking a joint.” The Louisiana House Health and Welfare Committee approved a Senate-passed bill to allow patients with terminal and irreversible conditions to use medical marijuana in hospitals, subject to certain limitations. A new poll of U.S. voters shows there’s been a “striking increase” in support for legal and regulated therapeutic access to psychedelics as well as expanded research exploring their medical potential over the last two years. / FEDERAL A U.S. Bankruptcy Court judge approved recognition of insolvency proceedings for the Cannabist Co. Sen. Susan Collins (R-ME) asked Federal Bureau of Investigation Director Kash Patel and Drug Enforcement Administration Administrator Terrance Cole about what their agencies are doing to address Chinese-linked illegal marijuana operations in Maine and other states during a Senate Appropriations Committee hearing. The House bill to regulate hemp products got one new cosponsor for a total of six. / STATES California’s attorney general touted enforcement actions against an unlicensed marijuana business. A Virginia delegate said he is cautiously optimistic that Gov. Abigail Spanberger (D) will allow his recreational marijuana sales legalization bill to take effect even after lawmakers rejected her proposed amendments. Michigan regulators are opening a second public comment period on proposed changes to marijuana rules. Colorado regulators published guidance on marijuana fee setting. Nevada regulators published a demographic study of the state’s cannabis industry. A member of the Oklahoma Medical Marijuana Executive Advisory Council was removed from her role. The New Jersey State Board of Medical Examiners temporarily suspended the license of a doctor who allegedly disregarded requirements for authorizing medical cannabis. New York regulators are recruiting participants for a study on CBD and THC in treating inflammatory bowel disease. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don\’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — / INTERNATIONAL The Victoria, Australia Legislative Council approved a to codify the state’s approach to issuing cautions for marijuana as an alternative to arrests. / SCIENCE & HEALTH A study found that “CBD treatment was associated with statistically and clinically significant [quality of life] improvement across multiple domains in children with drug-resistant epilepsy” and that “seizure frequency reduction was observed in the majority of patients.” A case series concluded that “psilocybin may enhance motor recovery and sensory integration in incomplete spinal cord injury through amplification of existing neural pathways and warrant controlled clinical trials.” / ADVOCACY, OPINION & ANALYSIS The Pennsylvania Democratic Party tweeted, “Stacy Garrity said the quiet part out loud: if she’s elected, recreational marijuana legalization in Pennsylvania isn’t happening. While Governor Josh Shapiro is fighting to keep revenue in Pennsylvania instead of losing it to neighboring states, she’s doubling down on an out-of-touch agenda that ignores the broad bipartisan support for legalization. PA is not her priority — her toxic agenda is.” / BUSINESS Glass House Brands Inc. reported quarterly net revenue of $40.5 million and a net loss of $17 million. Auxly Cannabis Group Inc. reported quarterly net revenue of C$39.8 million. Trulieve Cannabis Corp. is seeking shareholder approval to redomicile the company from British Columbia, Canada to Delaware. Stiiizy is being sued for allegedly concealing tracking tools on its website to monitor shopping habits and then selling the data to brokers. / CULTURE Opry Entertainment Group named Señorita as the official THC beverage partner for the Grand Ole Opry and other venues. Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox. Get our daily newsletter. Email address: Leave this field empty if you're human: The post Amendment to let military vets get medical cannabis approved at VA passes (Newsletter: May 15, 2026) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Drift Boss is an infinite game; there is no definitive endpoint. You may continue driving indefinitely, provided you remain on the course.

In the popular video game Run 3, your objective is to cover as much ground as possible in order to reach the finish line. This platform game is fast-paced and features hundreds of different levels for players to discover.

Geometry dash subzero takes the fast-paced action of the original Geometry Dash and drops it into a smooth, cold world. This game is great for people who like strong reaction-based platformers with a steady beat and cold graphics. Subzero has stylish graphics, frozen levels, and electrifying beats. It challenges players to time every jump perfectly as they navigate through frozen objects and sharp spikes.

Late-night loneliness can make even the busiest city feel surprisingly empty sometimes. That is why many people quietly choose Escort Service in Mahipalpur whenever they want feminine company that feels elegant and emotionally engaging. The experience becomes more enjoyable when the companion understands how to maintain playful energy while still creating emotional ease.

Virginia’s governor has signed legislation to provide resentencing relief for people with past marijuana convictions—even after lawmakers declined to adopt her proposed amendments to the legislation that would have significantly scaled back the scope of the reform. Gov. Abigail Spanberger (D) gave final approval to the bills, HB 26 from Rozia Henson, Jr. (D), and SB 62 from Senate President Pro Tem Louise Lucas (D), on Thursday. Separately, lawmakers and advocates are awaiting the governor’s action on separate legislation to legalize recreational marijuana sales after her proposed amendments were similarly rejected by the House and Senate last month. The suggested changes to that legislation included delaying the start date for sales by six months, increasing taxes and instituting new criminal penalties for cannabis consumers. The resentencing reform, meanwhile, creates a process by which people who are incarcerated or on community supervision for certain felony offenses involving the possession, manufacture, selling or distribution of marijuana will receive an automatic hearing to consider modification of their sentences. Spanberger last month had sent lawmakers suggested amendments that would have required affected persons to proactively file petitions to get the relief instead of having courts proceed automatically. The Senate and House of Delegates, however, declined to take up the proposal, effectively rejecting it and sending the original legislation back to Spanberger’s desk. Henson, the sponsor of the House version of the bill, had said he was willing to accept the governor’s changes even if he worried that it would mean that some people with cannabis convictions would “fall through the cracks simply because they lacked a lawyer or did not know to ask.” The full legislature did not agree to the changes, however, and now HB 26 and SB 62 as originally passed have been enacted into law. The relief will apply to people whose convictions or adjudications are for conduct that occurred prior to July 1, 2021, when a state law legalizing personal possession and home cultivation of marijuana went into effect. State and local corrections officials will be required to identify and notify eligible people of their rights for resentencing relief and then work with courts to schedule hearings automatically. Henson said last month that the resentencing legislation was “built for the people still paying the price for something Virginia has since made legal.” “If the commonwealth changed the law, it has an obligation to revisit the consequences still being borne by people convicted under the old one,” he said. The governor’s office claimed in a press release when she proposed her amendments that they “clarify that under no circumstances would reconsideration be allowed for violent offenses that remain illegal in Virginia—from armed burglary to firearm possession to distribution of fentanyl, heroin, and other dangerous drugs.” But Henson said that while he shares “the governor’s commitment to ensuring that violent offenders are not eligible for this relief; and that commitment is reflected in the bill itself, which already excluded individuals convicted of acts of violence under Virginia law.” Spanberger’s release last month did not make any mention of her major actual change to the bill, which is to remove its provisions for automatic relief for people with cannabis convictions. The governor’s amendment also proposed to remove deadlines for court hearings on resentencing relief. Similar legislation was approved by lawmakers last session but it was vetoed by then-Gov. Glenn Youngkin (R). Separately, Spanberger signed several other reform bills last month—including measures to protect the parental rights of marijuana consumers and allow patients to access medical cannabis in hospitals. Cannabis policy reform advocacy organizations, meanwhile, sent a letter earlier this month urging the governor to allow the adult-use marijuana sales bill to take effect. The post Virginia Governor Signs Marijuana Resentencing Bill After Lawmakers Rejected Her Amendments appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

The U.S. House of Representatives has voted to let military veterans receive recommendations for medical marijuana through their doctors at the Department of Veterans Affairs (VA)—while also approving a separate amendment focused on the therapeutic benefits of psychedelics. The cannabis proposal from Reps. Brian Mast (R-FL), Dave Joyce (R-OH) and Dina Titus (D-NV) passed by a voice vote on Thursday. If enacted into law, the amendment would prevent VA from enforcing a longstanding directive that has blocked its providers from assisting veterans with registering for state medical cannabis programs. Under current policy, VA doctors can discuss marijuana use with their patients, but they cannot fill out forms to help them actually get legal access to cannabis. As a result, veterans need to seek outside, often expensive, services from separate providers instead of being able to get assistance from their own doctors at VA. That would change under the new amendment from the co-chairs of the Congressional Cannabis Caucus, which is now attached to the Fiscal Year 2027 Military Construction, Veterans Affairs, and Related Agencies Appropriations Act. Mast, himself a military veteran who lost two legs during combat in Afghanistan, said on the floor ahead of the vote that medical cannabis programs “exist in a lot of states.” “And if former members of the military have doctors that they are seeing inside of the Department of Veterans Affairs, and if there’s a treatment option that they want to be considered, they want to know if it’s right for them, if it’s not right for them, if it doesn’t fit in good with other prescriptions that they have, you name it,” he said. “If they want to discuss it, they have to be able to discuss it with their doctor. That is the most important person for them to discuss it with, is their doctor.” “Whether the doctor says, ‘hey, it’s good or bad,’ that’s that’s up to the doctor to decide, but they have to be able to have that conversation,” Mast said. “I tell people often, I was in Afghanistan, lost two legs and a finger there. When I woke up in the hospital, I woke up on antidepressants, anti inflammatories, heavy sleep sedatives, a host of narcotic pain killers…and I weaned myself off of those things very quickly. That is not the case for all of my brothers and sisters. A lot of these narcotics that people are on and get placed on, especially after injuries are serious and very difficult to get off of, and leave long term, long term, lasting effects on them. There’s got to be an ability, again, for people inside the system to have that conversation with their doctor about whether that’s right.” Titus said that “cannabis is proven to help with a wide variety of medical issues that veterans face, including pain management, PTSD and opioid addiction.” “Instead of self medicating and going outside the VA system, the veterans should be able to speak with a doctor honestly about what their options are,” she said. “Our veterans deserve the best health care they can get, and should not be left behind because the federal government lags behind the states. They need to hear their options and make their choices.” I am pleased to see that the House Rules Committee made my and @RepBrianMast's amendment to allow medical marijuana recommendations @DeptVetAffairs in order. I will continue fighting to get this provision over the finish line. Our veterans deserve the best health care that they… — Dina Titus (@repdinatitus) May 14, 2026 Joyce said the amendment “is about ensuring veterans are not denied access to treatment options that may improve their quality of life. ” “Do you want them getting advice from doctors or budtenders?” he asked. “Simple question.” “Many of our service members return home bearing invisible wounds that last long after the battlefield,” Joyce said. “Chronic pain, PTSD, traumatic brain injuries, depression and other service-connected conditions that ca, profoundly affect the quality of their lives. Some veterans’ traditional treatments have not worked. Others are searching for alternatives that may help manage pain, improve daily functioning or reduce reliance on highly addictive opioids.” The veterans medical marijuana amendment reads: “SEC. __. None of the funds appropriated or otherwise made available to the Department of Veterans Affairs in this Act may be used to enforce Veterans Health Directive 1315 as it relates to— (1) the policy stating that ‘VHA providers are prohibited from completing forms or registering Veterans for participation in a State-approved marijuana program’; (2) the directive for the ‘Deputy Under Secretary for Health for Operations and Management’ to ensure that ‘medical facility Directors are aware that it is VHA policy for providers to assess Veteran use of marijuana but providers are prohibited from recommending, making referrals to or completing paperwork for Veteran participation in State marijuana programs’; and (3) the directive for the ‘VA Medical Facility Director’ to ensure that ‘VA facility staff are aware of the following’ ‘[t]he prohibition on recommending, making referrals to or completing forms and registering Veterans for participation in State-approved marijuana programs.'” While similar proposals on veterans’ medical marijuana access have been passed by both the House of Representatives and Senate in past years, they have never been enacted into law. Last year, when the House- and Senate-passed language was left out of the final bill sent to President Donald Trump, Mast told Marijuana Moment that the exclusion was “ridiculous.” “It was a great and easy opportunity to do so, and a sensical thing to move forward—and detrimental to veterans to not do so,” he said. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — The current amendment comes just weeks after medical marijuana was rescheduled under federal law by the Trump administration, a major policy and political development that advocates hope could boost the chances of the veterans-focused reform being enacted this year. A separate amendment to the military and veterans spending bill that was also approved on the floor in a voice vote on Thursday seeks to raise awareness about the benefits of psychedelic and other therapies for military veterans. Sponsored by Reps. Lou Correa (D-CA) and Jack Bergman (R-MI), who co-chair the Congressional Psychedelics Advancing Therapies Caucus, the amendment’s description says it “increases and decreases funding for the Medical and Prosthetic Research account at the Department of Veterans Affairs to emphasize the importance of the Department’s research on areas benefiting veterans such as oncology, traumatic brain injury care, psychedelic therapies, and assistive devices.” Correa noted ahead of the vote that President Donald Trump last month “signed an executive order to expedite psychedelic therapy research for depression and substance abuse disorder, specifically for veterans.” “This amendment is basically about taking care of those that have answered the call of duty to defend our country—those individuals have come back from combat with invisible wounds they still have not healed,” he said. “On a daily basis, 20 to 40 veterans take their lives commit suicide because of PTSD,” Correa said. “Many veterans have taken this treatment, and essentially been cured of PTSD… This is about treating our veterans’ invisible wounds.” Meanwhile in Congress, the House Appropriations Committee approved a bill this week containing provisions that would block Department of Justice officials from taking further steps to reschedule cannabis while continuing to protect state medical marijuana laws from federal interference. A report attached to that legislation also directs federal officials to take enforcement action against unregulated cannabinoid products that “threaten consumer safety.” Separately, that panel recently approved another spending bill and an attached report that expresses concerns about health risks from cannabis-derived products, while also encouraging research into the therapeutic benefits of psychedelics. The full House also recently passed a Farm Bill with provisions aimed at aiding industrial hemp producers—but without any language to delay or alter the federal recriminalization of hemp THC products that’s scheduled to take effect later this year. A new report from the Congressional Research Service details the scope and limitations of the federal marijuana rescheduling move. The post House Votes To Let Military Veterans Get Medical Marijuana Recommendations From VA Doctors appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net